- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate safety and tolerability during long-term treatment with degarelix one-month dosing regimen in prostate cancer patients
Critère d'inclusion
- Patients with histologically proven prostate cancer of all stages in whom endocrine treatment is indicated